Answers are grounded in this paper and cite their sources.
This research demonstrates enhanced radiotherapeutic outcomes in breast cancer through a novel nanoparticle treatment, implying improved patient therapies.
We designed a novel nanoplatform, Pt@BSA-RM, that is capable of sensitizing breast cancer cells to radiotherapy.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: